|
|
|
|
| LEADER |
03094nmm a2200745 u 4500 |
| 001 |
EB002165171 |
| 003 |
EBX01000000000000001302950 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841210592
|
| 050 |
|
4 |
|a QP632.E4
|
| 100 |
1 |
|
|a Anderson, Laurens
|e [editor]
|
| 245 |
0 |
0 |
|a Bacterial lipopolysaccharides
|b structure, synthesis, and biological activities : based on a symposium sponsored by the ACS Division of Carbohydrate Chemistry at the 184th Meeting of the American Chemical Society, Kansas City, Missouri, September 12-17, 1982
|c Laurens Anderson, editor, Frank M. Unger, editor
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 1983, 1983
|
| 300 |
|
|
|a 340 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Glycoconjugates / analysis
|
| 653 |
|
|
|a Bacterial Toxins / chemistry
|
| 653 |
|
|
|a Antibodies, Monoclonal
|
| 653 |
|
|
|a Immunotherapy
|
| 653 |
|
|
|a Lipoprotein(a) / chemical synthesis
|
| 653 |
|
|
|a Glycoconjugates / Analysis
|
| 653 |
|
|
|a MEDICAL / Evidence-Based Medicine / bisacsh
|
| 653 |
|
|
|a Bacterial Toxins / chemical synthesis
|
| 653 |
|
|
|a Polysaccharides / Structure
|
| 653 |
|
|
|a MEDICAL / Clinical Medicine / bisacsh
|
| 653 |
|
|
|a Cancer / Immunotherapy / Analysis
|
| 653 |
|
|
|a Bacterial toxins / Structure / Synthesis
|
| 653 |
|
|
|a Lipoprotein A / Synthesis / Methodology
|
| 653 |
|
|
|a Polysaccharides / Synthesis
|
| 653 |
|
|
|a Lipoprotein A / Synthesis
|
| 653 |
|
|
|a Lipoprotein A / Structure / Analysis
|
| 653 |
|
|
|a Neoplasms / therapy
|
| 653 |
|
|
|a Polysaccharides / chemistry
|
| 653 |
|
|
|a Salmonella / growth & development
|
| 653 |
|
|
|a Polysaccharides / chemical synthesis
|
| 653 |
|
|
|a Lipoprotein(a) / chemistry
|
| 653 |
|
|
|a HEALTH & FITNESS / Diseases / General / bisacsh
|
| 653 |
|
|
|a Endotoxins / Synthesis
|
| 653 |
|
|
|a MEDICAL / Internal Medicine / bisacsh
|
| 653 |
|
|
|a Oligosaccharides / chemical synthesis
|
| 653 |
|
|
|a Escherichia coli
|
| 653 |
|
|
|a Endotoxins / adverse effects
|
| 653 |
|
|
|a Oligosaccharides / Synthesis
|
| 653 |
|
|
|a Polysaccharides, Bacterial
|
| 653 |
|
|
|a Endotoxins
|
| 653 |
|
|
|a Monoclonal antibodies / Synthesis
|
| 653 |
|
|
|a Microbial polysaccharides
|
| 653 |
|
|
|a MEDICAL / Diseases / bisacsh
|
| 653 |
|
|
|a Lipopolysaccharides
|
| 653 |
|
|
|a Salmonella / Synthesis / Inhibitors
|
| 653 |
|
|
|a Endotoxins / chemical synthesis
|
| 653 |
|
|
|a Endotoxins / Health aspects
|
| 653 |
|
|
|a Growth Inhibitors
|
| 653 |
|
|
|a Escherichia coli / Synthesis / Inhibitors
|
| 700 |
1 |
|
|a Unger, Frank M.
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Carbohydrate Chemistry
|
| 710 |
2 |
|
|a American Chemical Society
|b Meeting ( 1982, Kansas City, Missouri)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-1983-0231
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616/.014
|